Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting

Inflammatory bowel disease (IBD) is a chronic inflammatory disease of the gastrointestinal tract with increasing incidence worldwide. Although a deeper understanding of the underlying mechanisms of IBD has led to new therapeutic approaches, treatment options are still limited. Severe adverse events...

Description complète

Détails bibliographiques

Auteurs principaux:	Markus Ries, Brice Moulari, Maryam A. Shetab Boushehri, Mohamed Ehab Ali, Daniel Molnar, Arnaud Béduneau, Yann Pellequer, Alf Lamprecht
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2022-02-01
Collection:	Pharmaceutics
Sujets:	adalimumab inflammatory bowel disease colitis inflammation surface-decorated nanoparticles
Accès en ligne:	https://www.mdpi.com/1999-4923/14/2/352
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!